EU Panel Recommends Fenspiride Suspension Because of Heart Risks EU Panel Recommends Fenspiride Suspension Because of Heart Risks

The potential risk of serious heart rhythm problems associated with fenspiride prompts the EMA ' s safety committee to recommend suspending its use pending further review.Medscape Medical News

Source: Medscape Medical News Headlines - February 15, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news